Skip to main content
. 2022 Sep 5;28(9):1813–1822. doi: 10.1038/s41591-022-01956-3

Extended Data Fig. 3. Adverse events.

Extended Data Fig. 3

Adverse events reported by at least 20% of participants. #e = number of events; #s = number of participants.